2022 annual financial data
Dogwood Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -12,315,309 USD and net income was -12,247,834 USD.
Operating cash flow was -11,467,797 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,315,309 USD
- Net income
- -12,247,834 USD
- Operating cash flow
- -11,467,797 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Dogwood Therapeutics financial years